D. E. Shaw & Co., Inc. Lucira Health, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.94 $8,326 - $22,781	-5,782 Reduced 29.43%	13,866 $26,000
Q1 2022 May 16, 2022	SELL	$2.86 - $8.83 $157,062 - $484,917	-54,917 Reduced 73.65%	19,648 $70,000
Q4 2021 Feb 14, 2022	BUY	$4.94 - $8.94 $368,351 - $666,611	74,565 New	74,565 $642,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.